Simultaneous analysis of the H1-antihistamine acrivastine and the decongestant pseudoephedrine hydrochloride by high-performance liquid chromatography.
Xiaochen Gu, Hongtao Li, Kyle R Macnair, F Estelle R Simons, Keith J Simons
Index: J. Pharm. Biomed. Anal. 37(4) , 663-7, (2005)
Full Text: HTML
Abstract
High-performance liquid chromatography (HPLC) was used for the simultaneous quantification of the H(1)-antihistamine acrivastine and the decongestant pseudoephedrine hydrochloride. Both compounds were detected at the wavelength of 214 nm. The influence of the mobile phase and the detection wavelength was evaluated and optimized. This method was used to assay various samples from studies of the commercial preparation Semprex-D capsules. The method was found to be accurate, specific, selective, rapid, and versatile for use in routine quality control analyses.
Related Compounds
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
 |
Acrivastine
CAS:87848-99-5 |
C22H24N2O2 |
|
Identification of novel functional inhibitors of acid sphing...
2011-01-01 [PLoS ONE 6 , e23852, (2011)] |
|
Onset-of-action for antihistamine and decongestant combinati...
2000-04-01 [Ann. Allergy Asthma Immunol. 84(4) , 451-9, (2000)] |
|
Efficacy of acrivastine plus pseudoephedrine for symptomatic...
1996-05-01 [Ann. Allergy Asthma Immunol. 76(5) , 432-8, (1996)] |
|
Quantification of antihistamine acrivastine in plasma by sol...
2007-01-04 [J. Pharm. Biomed. Anal. 43(1) , 293-7, (2007)] |
|
Evaluation and comparison of five matrix excipients for the ...
2004-01-01 [Drug Dev. Ind. Pharm. 30(10) , 1009-17, (2004)] |